Eurotimes Articles

  • 10/03/2013 - 18:03 GENE THERAPY 2013, Retina, Oct Advances in imaging technologies and the development of increasingly sophisticated testing methods are helping to drive forward efforts to quantify the therapeutic effect of clinical trials for hereditary retinal diseases, according to an expert in the field.
  • 10/01/2013 - 22:15 ANTI-VEGF 2013, Retina, Oct The inhibition of vascular endothelial growth factor provides a substantial long-term benefit in patients with macular oedema secondary to branch retinal vein occlusion, Sandra Rezar MD told delegates attending the 2013 Congress of the Society of European Ophthalmology (SOE).
  • 10/01/2013 - 22:12 AMD COMPLICATIONS 2013, Retina, Oct What is the optimal approach for treating a patient with macular degeneration who develops a submacular haemorrhage? Jan van Meurs MD, a vitreoretinal surgeon at the Rotterdam Eye Hospital, and colleagues have initiated a prospective clinical trial to compare existing treatments.
  • 09/02/2013 - 17:41 VITREOUS FLOATERS 2013, Retina, Sept The treatment of vitreous floaters is controversial. Surgical interventions are available, but are only rarely offered to select patients with symptomatic primary floaters, despite several small-scale studies that suggest that good results can be obtained, with great patient satisfaction and relatively low complication rates
  • 09/02/2013 - 17:36 PROPELLED BY PROGRESS 2013, Retina, Sept Francesco Bandello MD, FEBO, is the president-elect of EURETINA. He first became involved with the organisation when his mentor Rosario Brancato MD was working with Gisbert Richard MD to get the EURETINA meetings project started
  • 09/02/2013 - 17:34 PROMISING DATA 2013, Retina, Sept Navigated laser photocoagulation shows considerable promise as an adjunctive therapy to anti- VEGF treatments by significantly reducing the number of intravitreal injections needed to preserve vision in diabetic macular oedema (DME) patients, according to a study presented at the 2013 Congress of the Society of European Ophthalmology (SOE).
  • 09/02/2013 - 16:50 GENE THERAPY AND RETINAL DISEASE 2013, Retina, Sept, Headlines It has been estimated that one in every 4,000 people suffers from an inherited retinal disease and half of those affected have no family history of the pathology.
  • 09/02/2013 - 16:35 DIABETIC RETINOPATHY 2013, Retina, Sept Irish ophthalmology saw its long-awaited national diabetic screening programme, known as Diabetic Retina Screen, finally began its phased roll-out this year. The programme encountered many issues along the way including the cost of anti-VEGF injections, convincing treatment centres to sign up to a new funding model, and a healthcare staff recruitment embargo.
  • 07/15/2013 - 15:45 AREDS2 RESULTS 2013, Aug, Retina, Headlines In October 2001, results from the Age-Related Eye Disease Study (AREDS) were published and found that progression to advanced age-related macular degeneration (AMD) was reduced by about 25 per cent in high-risk individuals receiving high doses of antioxidant vitamins (C and E), beta-carotene and zinc.

Popular Items